Rwanda - Press Releases

SHANGHAI and HONG KONG, April 23, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that it will release the latest clinical data of the CD73 small molecule inhibitor ATG-037 and the mTORC1/2 small molecule inhibitor ATG-008 in Poster Presentations at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 30th to June 3rd in Chicago, IL, the United States.

CHENGDU, China, April 24, 2025 /PRNewswire/ -- SichuanKelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30 to June 3. Results include data from its TROP2 antibody-drug conjugate (ADC)sacituzumab tirumotecan(sac-TMT), anti-PD-L1 mAb tagitanlimab, and RET inhibitor KL590586 (A400/EP0031). The abstracts for these studies will be published on the ASCO's official website on May 22, 2025, local time.

Solid performance with higher sales and strong cash flow

Solid performance with higher sales and strong cash flow

SLOUGH, United Kingdom and RICHMOND, Va., April 24, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending March 31, 2025. The earnings release, investor presentation and webcast are available at www.indivior.com.

GOTHENBURG, Sweden, April 24, 2025 /PRNewswire/ --

Strong product sales and key progress in pipeline catalysts

Strong product sales and key progress in pipeline catalysts

- Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles -

YANTAI, China, 24. April 2025 /PRNewswire/ -- In der Neurochirurgie mit hohem Einsatzist die Gewinnung von Echtzeit-Einblicken in den zerebralen Blutfluss lebenswichtig, aber auch eine Herausforderung. Die herkmmliche Indocyaningrn (ICG)-Fluoreszenzbildgebung ist auf Kontrastmittel angewiesen und bietet nur eine begrenzte Wiederholbarkeit. Jetzt versprechen Infrarot-Thermografiekameras eine berhrungslose, kontrastfreie, strahlungsfreie und nicht-invasive Alternative zur diagnostischen Bildgebung, die eine kontinuierliche berwachung ermglicht und die chirurgische Przision und Patientensicherheit erhht.

-Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month -

-Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month -

CHANGZHOU, China, April 23, 2025 /PRNewswire/ -- STAK Inc. (the "Company" or "STAK")(Nasdaq: STAK), a fast-growing company specializing in the research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment, today announced its unaudited financial results for the first half of fiscal year 2025 ended December 31, 2024.

- Deliveries of 2,284 Homes Generating $903.2 Million in Total Revenues -- Net New Home Contracts of 2,692 -- Net Income of $39.4 Million, or $1.26 Per Diluted Share -- Adjusted Net Income of $42.2 Million, or $1.36 Per Diluted Share -- Community Count Increased 26% YoY to 318 -

Strong Revenue Growth Drives Double-Digit Increase in Earnings and Cash Flow

DOWNERS GROVE, Ill., April 23, 2025 /PRNewswire/ -- SWEP, part of Dover(NYSE: DOV)and a world-leading supplier of brazed plate heat exchangers (BPHEs), today announced the introduction of CO2-reduced steel as an option for customers seeking to minimize the carbon footprint of their heating systems and heat transfer projects.

HOUSTON, April 23, 2025 /PRNewswire/ -- Drilling Tools International Corp., (NASDAQ: DTI) ("DTI" or the "Company"), a global oilfield services company that designs, engineers, manufactures and provides a differentiated, rental-focused offering of tools for use in onshore and offshore horizontal and directional drilling operations, as well as other cutting-edge solutions across the well life cycle, today announced that it plans to report 2025 first quarter financial results prior to the Company's live conference call, which can be accessed via dial-in or webcast, on Wednesday, May 14, 2025 at 10:00a.m. Eastern Time (9:00 a.m. Central Time).

Teamsters Demand Fair National Standard for 2,000 Workers

Teamsters Demand Fair National Standard for 2,000 Workers

VANCOUVER, BC, April 23, 2025 /PRNewswire/ - WestFraser Timber Co. Ltd. ("West Fraser" or the "Company") (TSX andNYSE: WFG) announced the voting results from its Annual General Meeting held on Wednesday, April 23, 2025 in Quesnel, B.C.

WASHINGTON, April 23, 2025 /PRNewswire/ -- Students from Santa Monica, California, will connect with NASA astronautJonny Kim as he answers prerecorded science, technology, engineering, and mathematics-related questions aboard the International Space Station.

NAIROBI, Kenya, 23 avril 2025 /PRNewswire/ --Alors que la dynamique conomique mondiale volue, Harvest GroupSA a annonc le lancement officiel de ses oprations au Kenya, tirant parti de la position stratgique du pays en tant que plaque tournante du commerce rgional et de porte d'accs aux marchs africains en pleine expansion.

Kuwait-based real estate development company J3 has selected Yardi's real estate cloud-based platform to streamline residential operations and enhance property management

GUANGZHOU, China, April 24, 2025 /PRNewswire/ -- At its 137th session, China Import and Export Fair (Canton Fair) continues to demonstrate its capacity to respond swiftly to evolving global consumer trends. With its broad product range and competent pool of suppliers, the Fair offers overseas buyers an efficient, one-stop platform to source tailored solutions for emerging lifestyle demands, such as the growingglamping economy in North America and Europe.

GOSSELIES, Belgium and NANTES, France, April 24, 2025 /PRNewswire/ -- AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, today announced the formation of its Scientific Advisory Board (SAB), which is comprised of industry experts in autoimmune and inflammatory disease drug development. The SAB will work closely with the AbolerIS team to advance its lead program, ABO21009, a humanized anti-CD45RC monoclonal antibody, through Phase 1 for rheumatoid arthritis (RA). Pending clinical proof-of-concept in RA, the Company intends to broaden its development into other autoimmune diseases. Durable, long-term remission remains elusive in many autoimmune diseases such as RA. The SAB will also assist the AbolerIS management with the planned development of additional indications for ABO21009 and the expansion and subsequent development of the Company's portfolio.